Hydroxyethyl starch for resuscitation

Current Opinion in Critical Care

Volumn 19, Issue 4, 2013, Pages 321-325

  Haase, Nicolai ^a   Perner, Anders ^a  

^a Rigshospitalet   (Denmark)

Author keywords

haemostasis; hydroxyethyl starch; kidney; mortality; resuscitation

Indexed keywords

ALBUMIN; FRESH FROZEN PLASMA; GELATIN; HETASTARCH; LACTIC ACID; SODIUM CHLORIDE;

BLOOD; BLUNT TRAUMA; COLLOID; CRITICALLY ILL PATIENT; CRYSTALLOID; DETERIORATION; DISEASE SEVERITY; ERYTHROCYTE TRANSFUSION; FLUID RESUSCITATION; FLUID THERAPY; HEMOSTASIS; HUMAN; INJURY; INJURY SCALE; INTENSIVE CARE UNIT; INTENTION TO TREAT ANALYSIS; KIDNEY FAILURE; META ANALYSIS (TOPIC); MORTALITY; NEPHROTOXICITY; PARTIAL THROMBOPLASTIN TIME; PATIENT SAFETY; PENETRATING TRAUMA; POSTOPERATIVE HEMORRHAGE; PROTHROMBIN TIME; RANDOMIZED CONTROLLED TRIAL (TOPIC); RENAL REPLACEMENT THERAPY; REOPERATION; REVIEW; SEPSIS; SURGICAL PATIENT; SYSTEMATIC REVIEW (TOPIC); THROMBOCYTE TRANSFUSION; URINE VOLUME;

EID: 84880922742     PISSN: 10705295     EISSN: 15317072     Source Type: Journal    
DOI: 10.1097/MCC.0b013e3283632de6     Document Type: Review

References (38)

1. Finfer S, Liu B, Taylor C, et al. Resuscitation fluid use in critically ill adults: An international cross-sectional study in 391 intensive care units. Crit Care 2010; 14:R185
2. Bellmann R, Feistritzer C, Wiedermann CJ. Effect of molecular weight and substitution on tissue uptake of hydroxyethyl starch: A meta-Analysis of clinical studies. Clin Pharmacokinet 2012; 51:225-236
3. Bayer O, Reinhart K, Kohl M, et al. Effects of fluid resuscitation with synthetic colloids or crystalloids alone on shock reversal, fluid balance, and patient outcomes in patients with severe sepsis: A prospective sequential analysis. Crit Care Med 2012; 40:2543-2551
4. Akademisches Lehrkrankenhaus der Johannes Gutenberg-Universitä t Mainz. Hospital presents results of final report: Committee Completes Investigation in the Case of Dr Boldt; 2012. http://www.klilu.de/content/ veranstaltungen-presse/pressearchiv/2012/hospital-presents-results-of-final- report-commit tee-completes-investigation-in-the-case-of-dr-boldt/index-ger. html. [Accessed 5 March 2013
5. Editors-in-Chief Statement Regarding IRB approval of clinical trials by Joachim Boldt; 2011. http://www.aaeditor.org/EICJointStatement.pdf. [Accessed 5 March 2013
6. Reinhart K, Perner A, Sprung CL, et al. Consensus statement of the ESICM task force on colloid volume therapy in critically ill patients. Intensive Care Med 2012; 38:368-383
7. Perel P, Roberts I, Ker K. Colloids versus crystalloids for fluid resuscitation in critically ill patients. Cochrane Database Syst Rev 2013; 2:CD000567
8. Bunn F, Trivedi D. Colloid solutions for fluid resuscitation. Cochrane Database Syst Rev 2012; 7:CD001319
9. Dart AB, Mutter TC, Ruth CA, Taback SP. Hydroxyethyl starch (HES) versus other fluid therapies: Effects on kidney function. Cochrane Database Syst Rev 2010; 1:CD007594
10. Zarychanski R, Abou-Setta AM, Turgeon AF, et al. Association of hydroxyethyl starch administration with mortality and acute kidney injury in critically ill patients requiring volume resuscitation: A systematic review and meta-Analysis. J Am Med Assoc 2013; 309:678-688
11. Gattas DJ, Dan A, Myburgh J, et al. Fluid resuscitation with 6% hydroxyethyl starch (130/0.4 and 130/0.42) in acutely ill patients: Systematic review of effects on mortality and treatment with renal replacement therapy. Intensive Care Med 2013. [Epub ahead of print
12. Myburgh JA, Finfer S, Bellomo R, et al. Hydroxyethyl starch or saline for fluid resuscitation in intensive care. N Engl J Med 2012; 367:1901-1911
13. Perner A, Haase N, Guttormsen AB, et al. Hydroxyethyl starch 130/0.42 versus Ringer's acetate in severe sepsis. N Engl J Med 2012; 367:124-134
14. Guidet B, Martinet O, Boulain T, et al. Assessment of hemodynamic efficacy and safety fluid replacement in patients with severe sepsis: The CRYSTMAS study. Crit Care 2012; 16:R94
15. Haase N, Perner A, Hennings LI, et al. Hydroxyethyl starch 130/0.38-0. 45 versus crystalloid or albumin in patients with sepsis: Systematic review with meta-Analysis and trial sequential analysis BMJ 2013; 346:f839
16. Dubin A, Pozo MO, Casabella CA, et al. Comparison of 6% hydroxyethyl starch 130/0.4 and saline solution for resuscitation of the microcirculation during the early goal-directed therapy of septic patients. J Crit Care 2010; 25:659.e1-659.e8
17. Zhu G, Quan Z, Shao Y, et al. The study of hypertonic saline and hydroxyethyl starch treating severe sepsis. Zhongguo Wei Zhong Bing Ji Jiu Yi Xue 2011; 23:150-153
18. Lv J, Zhao H, Liu F, An Y. The influence of lactate Ringer solution versus hydroxyethyl starch on coagulation and fibrinolytic system in patients with septic shock. Zhongguo Wei Zhong Bing Ji Jiu Yi Xue 2012; 24:38-41
19. Dolecek M, Svoboda P, Kantorová I, et al. Therapeutic influence of 20% albumin versus 6% hydroxyethylstarch on extravascular lung water in septic patients: A randomized controlled trial. Hepatogastroenterology 2009; 56:1622-1628
20. Palumbo D, Servillo G, D'Amato L, et al. The effects of hydroxyethyl starch solution in critically ill patients. Minerva Anestesiol 2006; 72:655-664
21. James MFM, Michell WL, Joubert IA, et al. Resuscitation with hydroxyethyl starch improves renal function and lactate clearance in penetrating trauma in a randomized controlled study: The FIRST trial (Fluids in Resuscitation of Severe Trauma). Br J Anaesth 2011; 107:693-702
22. Finfer S. Hydroxyethyl starch in patients with trauma. Br J Anaesth 2012; 108:159-160; author reply 160-161
23. Reinhart K, Hartog CS. Hydroxyethyl starch in patients with trauma. Br J Anaesth 2012; 108:321-322; author reply 322-324
24. Feldheiser A, Pavlova V, Bonomo T, et al. Balanced crystalloid compared with balanced colloid solution using a goal-directed haemodynamic algorithm. Br J Anaesth 2013; 110:231-240
25. Lee JS, Ahn SW, Song JW, et al. Effect of hydroxyethyl starch 130/0.4 on blood loss and coagulation in patients with recent exposure to dual antiplatelet therapy undergoing off-pump coronary artery bypass graft surgery. Circ J 2011; 75:2397-2402
26. Navickis RJ, Haynes GR, Wilkes MM. Effect of hydroxyethyl starch on bleeding after cardiopulmonary bypass: A meta-Analysis of randomized trials. J Thorac Cardiovasc Surg 2012; 144:223-230
27. Kozek-Langenecker SA, Jungheinrich C, Sauermann W, Van der Linden P. The effects of hydroxyethyl starch 130/0.4 (6%) on blood loss and use of blood products in major surgery: A pooled analysis of randomized clinical trials. Anesth Analg 2008; 107:382-390
28. Haas T, Preinreich A, Oswald E, Pajk W. Effects of albumin 5% and artificial colloids on clot formation in small infants. Anaesthesia 2007; 62:1000-1007
29. Jin S-L, Yu B-W. Effects of acute hypervolemic fluid infusion of hydroxyethyl starch and gelatin on hemostasis and possible mechanisms. Clin Appl Thromb Hemost 2010; 16:91-98
30. Schramko A, Suojaranta-Ylinen R, Kuitunen A, et al. Rapidly degradable hydroxyethyl starch solutions impair blood coagulation after cardiac surgery: A prospective randomized trial. Anesth Analg 2009; 108:30-36
31. Schramko A, Suojaranta-Ylinen R, Kuitunen A, et al. Hydroxyethylstarch and gelatin solutions impair blood coagulation after cardiac surgery: A prospective randomized trial. Br J Anaesth 2010; 104:691-697
32. Mittermayr M, Streif W, Haas T, et al. Hemostatic changes after crystalloid or colloid fluid administration during major orthopedic surgery: The role of fibrinogen administration. Anesth Analg 2007; 105:905-917
33. Hamaji A, Hajjar L, Caiero M, et al. Volume replacement therapy during hip arthroplasty using hydroxyethyl starch (130/0.4) compared to lactated Ringer decreases allogeneic blood transfusion and postoperative infection. Rev Bras Anestesiol 2013; 63:27-44
34. Hanart C, Khalife M, De Villé A, et al. Perioperative volume replacement in children undergoing cardiac surgery: Albumin versus hydroxyethyl starch 130/0.4. Crit Care Med 2009; 37:696-701
35. Mukhtar A, Aboulfetouh F, Obayah G, et al. The safety of modern hydroxyethyl starch in living donor liver transplantation: A comparison with human albumin. Anesth Analg 2009; 109:924-930
36. Yang J, Wang W-T, Yan L-N, et al. Alternatives to albumin administration in hepatocellular carcinoma patients undergoing hepatectomy: An open, randomized clinical trial of efficacy and safety. Chin Med J (Engl) 2011; 124:1458-1464
37. Van Der Linden P, James M, Mythen M, Weiskopf RB. Safety of modern starches used during surgery. Anesth Analg 2013; 116:35-48
38. Hartog CS, Kohl M, Reinhart K. A systematic review of third-generation hydroxyethyl starch (HES 130/0.4) in resuscitation: Safety not adequately addressed. Anesth Analg 2011; 112:635-645